Atovaquone and Proguanil Hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Dispensing Solutions, Inc.. The primary component is Atovaquone; Proguanil Hydrochloride.
Product ID | 68258-1104_0f8b0d18-94a9-4e99-a354-0f0fc40039dd |
NDC | 68258-1104 |
Product Type | Human Prescription Drug |
Proprietary Name | Atovaquone and Proguanil Hydrochloride |
Generic Name | Atovaquone And Proguanil Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2011-08-18 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA091211 |
Labeler Name | Dispensing Solutions, Inc. |
Substance Name | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
Active Ingredient Strength | 250 mg/1; mg/1 |
Pharm Classes | Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2011-08-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA091211 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-08-18 |
Inactivation Date | 2019-11-27 |
Marketing Category | ANDA |
Application Number | ANDA091211 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-08-18 |
Inactivation Date | 2019-11-27 |
Marketing Category | ANDA |
Application Number | ANDA091211 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-08-18 |
Inactivation Date | 2019-11-27 |
Marketing Category | ANDA |
Application Number | ANDA091211 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-08-18 |
Inactivation Date | 2019-11-27 |
Marketing Category | ANDA |
Application Number | ANDA091211 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-08-18 |
Inactivation Date | 2019-11-27 |
Marketing Category | ANDA |
Application Number | ANDA091211 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-08-18 |
Inactivation Date | 2019-11-27 |
Ingredient | Strength |
---|---|
ATOVAQUONE | 250 mg/1 |
SPL SET ID: | f8659107-ef6b-4142-a4b8-6934aae07f41 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0378-4160 | Atovaquone and Proguanil Hydrochloride | atovaquone and proguanil hydrochloride |
0378-4162 | Atovaquone and Proguanil Hydrochloride | atovaquone and proguanil hydrochloride |
10544-909 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
33261-900 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
42254-150 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
43063-393 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
50090-1302 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
68001-245 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
68258-1104 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
68462-404 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
60760-498 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
63187-879 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
43063-522 | Atovaquone and Proguanil HCl | atovaquone and proguanil hydrochloride |
50090-2980 | Atovaquone and Proguanil HCl | atovaquone and proguanil hydrochloride |
0173-0675 | MALARONE | atovaquone and proguanil hydrochloride |
0173-0676 | MALARONE | atovaquone and proguanil hydrochloride |
50090-0687 | MALARONE | atovaquone and proguanil hydrochloride |
50090-0688 | MALARONE | atovaquone and proguanil hydrochloride |